
    
      This will be a Phase I/II study evaluating the effectiveness and toxicity of a combined
      regimen of 7.25 Gy every other day fractions to a total dose of 36.25 Gy (total of 5
      fractions) with androgen deprivation therapy (ADT) for 4 months total.
    
  